Leerink Partnrs Issues Negative Forecast for Xencor Earnings
Xencor, Inc. (NASDAQ:XNCR – Free Report) – Leerink Partnrs cut their Q2 2025 earnings estimates for shares of Xencor in a research report issued on Wednesday, May 7th. Leerink Partnrs analyst J. Chang now expects that the biopharmaceutical company will earn ($0.77) per share for the quarter, down from their prior forecast of ($0.66). The […]
Xencor, Inc. (NASDAQ:XNCR – Free Report) – Leerink Partnrs cut their Q2 2025 earnings estimates for shares of Xencor in a research report issued on Wednesday, May 7th. Leerink Partnrs analyst J. Chang now expects that the biopharmaceutical company will earn ($0.77) per share for the quarter, down from their prior forecast of ($0.66). The […]
